Session Details

S020 New Innovations in Dermatology: What Devices and Treatments You Will Be Using in the Next 1-5 Years

Sat, Mar 28, 9:00 AM - 12:00 PM
Four Seasons 1
3 CME Available Symposium
View Map

DESCRIPTION

This session will be devoted towards examining the cutting-edge changes in the practice of medical and aesthetic dermatology s in terms of treatments and technologies. This session will emphasize current and forward-looking “game changers” that will transform the delivery of dermatologic care for the benefit of our patients featuring the world leaders creating this innovation.

LEARNING OBJECTIVES

1.

Describe future innovations in the treatment of medical and aesthetic dermatology new treatments in dermatology.

2.

Explain the scientific foundation for new innovations in medical and aesthetic dermatology

3.

Predict new devices to become routine parts of clinical practice in the next 1-5 years.

SCHEDULE

9:00 AM

What innovations will change the way we practice dermatology in the next 1-5 years?

Richard Rox Anderson, MD, FAAD

9:20 AM

What role will energy-based devices play in the treatment & prevention of skin cancer?

Mathew M. Avram, MD, JD, FAAD

9:40 AM

What innovations will change the way we treat vitiligo & pigment in the next 5 years?

John Harris, MD, PhD, FAAD

10:00 AM

Questions & Discussion

Richard Rox Anderson, MD, FAAD, John Harris, MD, PhD, FAAD

10:15 AM

Emerging treatments for hair loss targeting dormant follicles

Arash Mostaghimi, MD, MPH, FAAD

10:30 AM

What innovations in botulinum toxins & soft tissue filler will change the way we treat our patients?

Jeremy Green, MD, FAAD

10:50 AM

Changing the paradigm: how we will transform the treatment of nonmelanoma skin cancer

Christopher B. Zachary, MD

11:00 AM

Questions & Discussion

Jeremy Green, MD, FAAD, Arash Mostaghimi, MD, MPH, FAAD, Christopher B. Zachary, MD

11:10 AM

What laser & other energy-based devices you will be using in the next 1-2 years

Roy G. Geronemus, MD, FAAD

11:25 AM

How innovations will change medical treatment in dermatology in the next 5 years, and further

Dieter Manstein, MD, PhD

11:40 AM

What innovations will transform the way we perform regenerative medicine in dermatology?

Saranya P. Wyles, MD, PhD, FAAD

11:55 AM

Questions & Discussion

Roy G. Geronemus, MD, FAAD, Dieter Manstein, MD, PhD, Saranya P. Wyles, MD, PhD, FAAD

DIRECTOR

Mathew M. Avram, MD, JD, FAAD

Mathew M. Avram, MD, JD, FAAD

SPEAKERS

Richard Rox Anderson, MD, FAAD

Richard Rox Anderson, MD, FAAD

Roy G. Geronemus, MD, FAAD

Roy G. Geronemus, MD, FAAD

Jeremy Green, MD, FAAD

Jeremy Green, MD, FAAD

John Harris, MD, PhD, FAAD

John Harris, MD, PhD, FAAD

Dieter Manstein, MD, PhD

Dieter Manstein, MD, PhD

Arash Mostaghimi, MD, MPH, FAAD

Arash Mostaghimi, MD, MPH, FAAD

Brigham and Women's Hospital

Saranya P. Wyles, MD, PhD, FAAD

Saranya P. Wyles, MD, PhD, FAAD

Christopher B. Zachary, MD

Christopher B. Zachary, MD

HANDOUTS

Login to view handouts

DISCLOSURES

Richard Rox Anderson, MD, FAAD

Accure Acne Inc. – Advisory Board(Stock); AVAVA, LLC – Advisory Board(Stock); Blossom Innovations, LLC – Founder(Stock); Brixton Biosciences – Founder(Stock); Cytrellis Biosystems, Inc – Advisory Board(Stock); Massachusetts General Hospital – Employee(Patent royalties or other compensation for Intellectual Property Rights); Sofregen Medical, Inc. – Consultant(Stock Options);

Mathew M. Avram, MD, JD, FAAD

Allergan, Inc – Consultant (1099 relationship)(Fees); Cytrellis Biosystems, Inc – Consultant(Stock), Consultant(Stock Options); La Jolla NanoMedical – Consultant (1099 relationship)(Stock Options); Sofwave – Consultant (1099 relationship)(Stock Options);

Roy G. Geronemus, MD, FAAD

Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);

Jeremy Green, MD, FAAD

Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amplifica – Investigator(Grants/Research Funding); Appiell Inc. – Advisory Board(Stock Options); Candesant Biomedical, Inc. – Stockholder(Stock); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Advisory Board(Honoraria); Ipsen – Advisory Board(Honoraria), Investigator(Grants/Research Funding); L'Oréal Research and Innovation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Nordberg Medical – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Revelle Aesthetics, Inc. – Advisory Board(Stock Options); Rion Aesthetics – Speaker(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); Sinclair Pharma – Investigator(Grants/Research Funding); VeraDermics Inc. – Investigator(Grants/Research Funding);

John Harris, MD, PhD, FAAD

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aclaris Therapeutics, Inc. – Consultant(Fees); Aldena Therapeutics – Consultant(Fees), Founder(Stock); Almirall – Consultant(Fees); Alys Pharmaceuticals – Founder(Salary), Stockholder Private Company(Fees); Bain Capital – Consultant (1099 relationship)(Fees); Barinthus Biotherapeutics North America, Inc. – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Boxer Capital Management, LLC – Consultant (1099 relationship)(Fees); Cour Pharmaceuticals – Investigator(Grants/Research Funding); Dren Bio – Investigator(Grants/Research Funding); Granular Therapeutics – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Klirna Biotech, Inc. – Founder(Stock); Klirna Therapeutics – Founder(Stock); Leo Pharma Inc – Investigator(Grants/Research Funding); NexImmune – Investigator(Grants/Research Funding); Nira Biosciences, Inc. – Consultant(Fees), Founder(Stock); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Villaris Therapeutics, Inc – Founder(Stock), Investigator(Grants/Research Funding); Vimela – Consultant(Honoraria), Stockholder(Stock); Vividion Therapeutics – Consultant (1099 relationship)(Fees);

Dieter Manstein, MD, PhD

AVAVA, LLC – Consultant(Honoraria); Avava, LLC – Stockholder(Stock); Blossom Innovations, LLC – Stockholder(Stock); GME German Medical Engineering GmbH – Stockholder(Stock); R2 Dermatology, Inc. – Consultant(Honoraria), Other(Patent royalties or other compensation for Intellectual Property Rights); Soltego – Other(Stock); Syneron Candela – Other(Patent royalties or other compensation for Intellectual Property Rights); Zeltiq Aesthetics – Other(Patent royalties or other compensation for Intellectual Property Rights);

Arash Mostaghimi, MD, MPH, FAAD

AbbVie – Consultant(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Equillium, Inc. – Consultant(Fees); Hims – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Indomo – Consultant (1099 relationship)(Fees); Legacy Healthcare – Consultant (1099 relationship)(Fees); Olaplex – Advisory Board(Fees); Pelage Pharmaceuticals – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);

Saranya P. Wyles, MD, PhD, FAAD

Allergan Aesthetics – Consultant(Grants/Research Funding); Colorescience – Consultant (1099 relationship)(Fees); Elm Biosciences – Advisory Board(No Compensation Received); Estee Lauder – Advisory Board(Fees); Kenvue – Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Fees); Lumisque – Investigator(Grants/Research Funding); Merz Aesthetics – Speaker(Fees); Rapalogix Health – Investigator(Grants/Research Funding); Rion Aesthetics – Consultant (1099 relationship)(Fees);

Christopher B. Zachary, MD

Michelson Diagnostics Ltd. – Investigator(Equipment); Sciton Inc. – Investigator(Stock Options);